Related Experiment Videos

Patterns of drug-induced cardiovascular pathology in the beagle dog: relevance for humans

P Greaves1

  • 1Safety of Medicines Group, ZENECA Pharmaceuticals, Macclesfield, Cheshire, UK.

Insights

Pathological changes in toxicity studies are key but may be misleading. Integrating functional data with pathology in beagle dogs is crucial for understanding drug mechanisms and human risk.

Area of Science:

  • Toxicology
  • Cardiovascular Pharmacology
  • Drug Safety Evaluation

Background:

  • Pathological examination of tissue sections is standard for identifying organ toxicity and drug hazards.
  • Understanding the mechanisms of toxicity is crucial for accurate hazard characterization and human risk assessment.
  • Cardiovascular pathology patterns can be misleading without additional functional data.

Purpose of the Study:

  • To highlight the importance of integrating functional and pathological data in cardiovascular toxicity studies.
  • To emphasize the role of the beagle dog model in assessing novel cardiovascular drugs.
  • To underscore the necessity of mechanistic information for interpreting drug-induced pathological changes.

Main Methods:

  • Review of pathological alterations in drug toxicity studies.
  • Integration of in vivo/in vitro physiological, pharmacological, and biochemical data.
  • Utilizing the beagle dog model for correlating hemodynamic changes with pathological findings.

Main Results:

  • Pathological changes alone may not fully elucidate toxicity mechanisms.
  • Specific cardiovascular pathologies can arise from diverse underlying processes.
  • The beagle dog model allows for relating functional and structural changes.

Conclusions:

  • A comprehensive understanding of drug-induced cardiovascular toxicity requires combining pathological findings with mechanistic data.
  • The beagle dog is a valuable model for cardiovascular safety assessment due to its capacity to link hemodynamic and pathological alterations.
  • Accurate human risk assessment for novel cardiovascular drugs relies on integrated mechanistic and pathological evaluations.

Related Concept Videos